Park2 global knockout mice display a decrease in survival and develop larger infarcts than wild-type (WT) mice after MI (53), and cardiomyocyte-specific deletion of Park2 manifests cardiac hypertrophy at birth and early lethality (54). The gene discussed is PRKN; the disease is cardiac hypertrophy.